journal article·2023-12-26

Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy

Yuelin Fang, Susu Huang, Qiaoying Hu, Jicheng Zhang, Julia A. King, Yanqing Wang, Zhijian Wei, Jinghui Lu, Zhijing He, Xinru Kong, Xiaoye Yang, Jianbo Ji, Junjie Li, Guangxi Zhai, Lei Ye

ACS Nano· Volume 17· Issue 24
Publisher page

Abstract

Surgical resection is the first-line therapy for breast cancer. However, residual tumor cells and the highly immunosuppressive tumor microenvironment (TME) continue to have a serious impact on tumor recurrence and metastasis postresection. Implantation of an in situ hydrogel system postresection has shown to be an effective treatment with great clinical potential. Herein, an injectable zwitterionic hydrogel system was developed for local drug delivery with enhanced immune activation and prevention of tumor recurrence. Driven by electrostatic interactions, poly(sulfobetaine methacrylate) (PSBMA) self-assembles into a hydrogel in saline, achieving low protein adsorption and tunable biodegradability. The chemotherapy drug doxorubicin (DOX) was loaded into copper peroxide nanoparticles (CuO 2 /DOX), which were coated with macrophage membranes to form tumor-targeting nanoparticles (M/CuO 2 /DOX). Next, M/CuO 2 /DOX and the stimulator of interferon genes (STING) agonist 2′,3′-cGAMP were coloaded into PSBMA hydrogel (Gel@M/CuO 2 /DOX/STING). The hydrophilic STING agonist was first released by diffusion from hydrogel to activate the STING pathway and upregulate interferon (IFN) signaling related genes, remodeling the immunosuppressive TME. Then, M/CuO 2 /DOX targeted the residual tumor cells, combining with DOX-induced DNA damage, immunogenic tumor cell death, and copper death. Hence, this work combines chemodynamic therapy with STING pathway activation in TME, encouraging residual tumor cell death, promoting the maturation of dendritic cells, enhancing tumor-specific CD8 + T cell infiltration, and preventing postoperative recurrence and metastasis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China

Department of Chemical Engineering, University of Washington, Seattle, Washington 98195, United States

Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China

Department of Orthopaedics, Qilu Hospital of Shandong University, Shandong University Centre for Orthopaedics, Advanced Medical Research Institute, Shandong University, Jinan, Shandong 250012, China

Department of Hernia and Abdominal Wall Surgery, General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China

Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Shandong Provincial Program of Taishan Industrial Experts · National Science and Technology Major Special Project - Major New Drug Creation

References (72)

Show source-provided references
1. 10.1016/j.msec.2021.11239010.1016/j.msec.2021.112390 ↗
2. 10.1016/j.semcancer.2021.03.00810.1016/j.semcancer.2021.03.008 ↗
3. 10.1200/JCO.2022.40.16_suppl.100710.1200/JCO.2022.40.16_suppl.1007 ↗
4. 10.1038/nnano.2015.34310.1038/nnano.2015.343 ↗
5. 10.1038/s41467-022-33891-910.1038/s41467-022-33891-9 ↗
6. 10.1021/acs.nanolett.2c0050010.1021/acs.nanolett.2c00500 ↗
7. 10.1038/nrclinonc.2017.19410.1038/nrclinonc.2017.194 ↗
8. 10.1002/adfm.20230019910.1002/adfm.202300199 ↗
9. 10.1002/adma.20190324210.1002/adma.201903242 ↗
10. 10.1002/adfm.20200574710.1002/adfm.202005747 ↗
11. 10.1021/acsnano.3c0101910.1021/acsnano.3c01019 ↗
12. 10.2147/IJN.S26167110.2147/IJN.S261671 ↗
13. 10.1016/j.biomaterials.2021.12132810.1016/j.biomaterials.2021.121328 ↗
14. 10.1016/j.bioactmat.2022.07.00110.1016/j.bioactmat.2022.07.001 ↗
15. 10.1016/j.jconrel.2020.11.03910.1016/j.jconrel.2020.11.039 ↗
16. 10.1016/j.jconrel.2018.07.01110.1016/j.jconrel.2018.07.011 ↗
17. 10.1021/acs.accounts.2c0068110.1021/acs.accounts.2c00681 ↗
18. 10.3390/ijms2019467110.3390/ijms20194671 ↗
19. 10.1021/acsnano.8b0774610.1021/acsnano.8b07746 ↗
20. 10.1038/s41467-023-35902-910.1038/s41467-023-35902-9 ↗
21. 10.1038/s41578-023-00552-210.1038/s41578-023-00552-2 ↗
22. 10.1002/jbm.a.3706210.1002/jbm.a.37062 ↗
23. 10.1002/mabi.20210003910.1002/mabi.202100039 ↗
24. 10.1002/adfm.20190278510.1002/adfm.201902785 ↗
25. 10.1002/advs.20230063710.1002/advs.202300637 ↗
26. 10.1038/s41467-022-32160-z10.1038/s41467-022-32160-z ↗
27. 10.1016/j.biomaterials.2022.12187210.1016/j.biomaterials.2022.121872 ↗
28. 10.1002/adfm.20220608410.1002/adfm.202206084 ↗
29. 10.1002/adma.20227016210.1002/adma.202270162 ↗
30. 10.1002/adfm.20220130610.1002/adfm.202201306 ↗
31. 10.1016/j.cej.2021.13325510.1016/j.cej.2021.133255 ↗
32. 10.1021/acs.chemmater.0c0088910.1021/acs.chemmater.0c00889 ↗
33. 10.1002/adfm.20200943110.1002/adfm.202009431 ↗
34. 10.1073/pnas.201249111710.1073/pnas.2012491117 ↗
35. 10.1021/acsami.6b0309810.1021/acsami.6b03098 ↗
36. 10.1016/j.actbio.2022.12.04510.1016/j.actbio.2022.12.045 ↗
37. 10.1016/j.matdes.2023.11172710.1016/j.matdes.2023.111727 ↗
38. 10.1002/adma.20210422310.1002/adma.202104223 ↗
39. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
40. 10.1016/j.cej.2021.12903610.1016/j.cej.2021.129036 ↗
41. 10.1039/C6CS00592F10.1039/C6CS00592F ↗
42. 10.1002/adma.20200689210.1002/adma.202006892 ↗
43. 10.1002/adma.20210398010.1002/adma.202103980 ↗
44. 10.1016/j.biomaterials.2021.12098710.1016/j.biomaterials.2021.120987 ↗
45. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
46. 10.1021/acsnano.2c0463010.1021/acsnano.2c04630 ↗
47. 10.1016/j.cej.2021.13346610.1016/j.cej.2021.133466 ↗
48. 10.1002/smll.20200180510.1002/smll.202001805 ↗
49. 10.1038/nrc338010.1038/nrc3380 ↗
50. 10.1002/adma.20200205410.1002/adma.202002054 ↗
51. 10.1021/acs.nanolett.7b0526310.1021/acs.nanolett.7b05263 ↗
52. 10.1016/j.bioactmat.2022.09.02710.1016/j.bioactmat.2022.09.027 ↗
53. 10.1186/s12943-020-01250-110.1186/s12943-020-01250-1 ↗
54. 10.1038/s41467-023-37217-110.1038/s41467-023-37217-1 ↗
55. 10.1038/s41551-020-0597-710.1038/s41551-020-0597-7 ↗
56. 10.1002/adma.20200757610.1002/adma.202007576 ↗
57. 10.1021/acs.chemrev.1c0075010.1021/acs.chemrev.1c00750 ↗
58. 10.1021/acsnano.2c1176410.1021/acsnano.2c11764 ↗
59. 10.1038/s41565-022-01134-z10.1038/s41565-022-01134-z ↗
60. 10.1002/smll.20200697010.1002/smll.202006970 ↗
61. 10.1021/acs.nanolett.1c0497710.1021/acs.nanolett.1c04977 ↗
62. 10.1038/s41422-020-0346-110.1038/s41422-020-0346-1 ↗
63. 10.1038/s41467-021-22572-810.1038/s41467-021-22572-8 ↗
64. 10.1002/adma.20200839510.1002/adma.202008395 ↗
65. 10.1039/C9RA10736C10.1039/C9RA10736C ↗
66. 10.1021/acs.biomac.2c0148910.1021/acs.biomac.2c01489 ↗
67. 10.1016/j.biomaterials.2004.10.00410.1016/j.biomaterials.2004.10.004 ↗
68. 10.1002/anie.20150093410.1002/anie.201500934 ↗
69. 10.1016/j.cej.2021.12903710.1016/j.cej.2021.129037 ↗
70. 10.1016/j.biomaterials.2022.12183210.1016/j.biomaterials.2022.121832 ↗
71. 10.1021/acsami.1c0564410.1021/acsami.1c05644 ↗
72. 10.1021/acsnano.0c0539210.1021/acsnano.0c05392 ↗